SIMILASAN Inflammations gorge glob 15 g

7680509370472 CH-50937 20.01.1.
SIMILASAN Inflammations gorge glob 15 g
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5093701
CPT
-
Packaging group
15
Unit
g
Composition
apis mellifica (HAB) D10 2.5 mg, atropa bella-donna (HAB) D8 (HAB 2a) 2.5 mg, hydrargyrum biiodatum (HAB) D12 (HAB 5a) 2.5 mg, lachesis (HAB) D12 (HAB SV, 5a) 2.5 mg, calcii carbonas, xylitolum 600 mg, ad globulos pro 1 g, corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Halsentzündungen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/08/2026
Patient information leaflet
Français
12/08/2026
Patient information leaflet
Italien
12/08/2026

Detailed composition

Substance Quantity Type Category
apis mellifica (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
atropa bella-donna (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
hydrargyrum biiodatum (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
lachesis (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
600.0 MG Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50937
Drug name
Similasan Halsentzündungen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
14/08/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild kann Similasan Halsentzündungen, Globuli bei akuten und chronischen, schmerzhaften Halsentzündungen angewendet werden

Packaging details

Description (FR)
SIMILASAN Inflammations gorge glob 15 g
Description (DE)
SIMILASAN Halsentzündungen Glob 15 g
Market launch
14/08/1991
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data